Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAN
2151
DELISTED
The Aaron's Company Inc
AAN
| $15.2M | ﹤0.01% |
552,507
-54,348
| -9% | -$1.53M |
|
|
KRON
2152
DELISTED
Kronos Bio
KRON
| $15.2M | ﹤0.01% |
725,608
+254,585
| +54% | +$5.47M |
|
2153
New Oriental
EDU
$8.33B
| $15.2M | ﹤0.01% |
746,081
+236,773
| +46% | +$7.52M |
|
2154
JFrog
FROG
$11.5B
| $15.2M | ﹤0.01% |
453,593
-11,230
| -2% | -$451K |
|
|
CAI
2155
DELISTED
CAI International, Inc.
CAI
| $15.2M | ﹤0.01% |
271,690
+3,118
| +1% | +$174K |
|
2156
FIGS
FIGS
$2.47B
| $15.2M | ﹤0.01% |
+408,511
| New | +$16.5M |
|
2157
Columbia Financial
CLBK
$1.22B
| $15.1M | ﹤0.01% |
817,831
+5,366
| +0.7% | +$96K |
|
2158
1st Source
SRCE
$2.13B
| $15.1M | ﹤0.01% |
319,934
-1,256
| -0.4% | -$57.2K |
|
2159
Utz Brands
UTZ
$1.25B
| $15.1M | ﹤0.01% |
882,135
-12,567
| -1% | -$255K |
|
|
WW
2160
DELISTED
WW International
WW
| $15.1M | ﹤0.01% |
826,366
-76,417
| -8% | -$2M |
|
2161
Advantage Solutions
ADV
$423M
| $15.1M | ﹤0.01% |
69,608
-504
| -0.7% | -$118K |
|
2162
Nicolet Bankshares
NIC
$3.73B
| $15M | ﹤0.01% |
202,512
+43,806
| +28% | +$3.2M |
|
2163
A10 Networks
ATEN
$1.96B
| $15M | ﹤0.01% |
1,114,333
+10,202
| +0.9% | +$132K |
|
|
TDAY
2164
USA Today Co
TDAY
$1B
| $15M | ﹤0.01% |
2,247,750
-3,304
| -0.1% | -$19.4K |
|
2165
ADT
ADT
$5.46B
| $15M | ﹤0.01% |
1,854,200
+10,332
| +0.6% | +$95.2K |
|
2166
Standard Motor Products
SMP
$870M
| $14.9M | ﹤0.01% |
341,744
-426
| -0.1% | -$18.3K |
|
|
TRIL
2167
DELISTED
Trillium Therapeutics Inc.
TRIL
| $14.9M | ﹤0.01% |
850,207
+10,318
| +1% | +$121K |
|
2168
Banc of California
BANC
$3.11B
| $14.9M | ﹤0.01% |
806,941
+42,656
| +6% | +$746K |
|
|
INBX
2169
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $14.9M | ﹤0.01% |
446,223
+126,382
| +40% | +$3.85M |
|
|
INVX
2170
Innovex International
INVX
$2.15B
| $14.8M | ﹤0.01% |
589,708
+6,232
| +1% | +$166K |
|
2171
Replimune Group
REPL
$1.42B
| $14.8M | ﹤0.01% |
499,506
+29,712
| +6% | +$965K |
|
|
NTUS
2172
DELISTED
Natus Medical Inc
NTUS
| $14.8M | ﹤0.01% |
590,289
+2,693
| +0.5% | +$68.6K |
|
|
PAYA
2173
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $14.8M | ﹤0.01% |
1,360,409
+121,135
| +10% | +$1.31M |
|
2174
ImmunityBio
IBRX
$8.11B
| $14.8M | ﹤0.01% |
1,516,256
+46,560
| +3% | +$512K |
|
|
LOGC
2175
DELISTED
ContextLogic
LOGC
| $14.7M | ﹤0.01% |
90,012
+55,664
| +162% | +$13.9M |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.